Stavros Tousios

Stavros Tousios

Expertise: FX, Macros, Equity Analysis, Investment Advisory

Education: MBA, MEng in Electronics, Sussex University, U.K.

Awards & Accomplishments: CySEC Licenced, Investment Advisor

Stavros Tousios, MBA, is a contributor at InvestorPlace.com, where he offers investors strategic guidance and valuable insights to enhance their evaluation of investment opportunities.

His dedication to delivering accurate and in-depth analysis positions him as a trusted resource for individuals and businesses seeking to make informed investment decisions.

As the founder and chief analyst of Markets Untold, an investment content company, Stavros provides unique and valuable insights to financial brands, including renowned Forex brokers and other industry leaders.

Beyond his current role at Markets Untold, Stavros also serves as an investment advisor at a Forex broker based in Cyprus. Leveraging his extensive background and qualifications, he offers valuable recommendations and advice to clients seeking to optimize their trading strategies.

With a focus on in-depth equity research, he has earned a reputation as an authority in the field. He has collaborated with former Bloomberg analysts and contributed to prominent platforms recognized for their comprehensive equity research.

During his tenure leading the investment research department at a renowned Forex broker, Stavros further solidified his position as a trusted and knowledgeable professional. He built and led a team of market strategists and content providers to successfully provide buy-side investment research to Reuter’s institutional platform, Eikon.

Recent Articles

3 Near-Overbought Stocks to Buy for Fast Gains

Get in on these near-overbought stocks to buy with strong upward momentum while they still have room to grow.

The Top 3 Stocks to Watch This Week

There are three stocks to watch this week as they experienced significant price movements worth your attention.

Stocks to Watch: 3 At-Risk Companies That Rely on Red Sea Shipping Routes

These three stocks are being affected by Red Sea shipping disruptions. Learn how they are impacted and what it means for investors.

The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs

Next gen biotech stocks such as Pfizer, Exscientia, and GSK leverage AI to drive biotech breakthroughs, shaping the future of the industry.

3 Top-Rated EV Charging Stocks Wall Street Analysts Are Loving Now: January 2024

With tax credits, more infrastructure funds and an improving economy, now is the time to dig into top-rated EV charging stocks.